Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer

  • Technology appraisal guidance
  • TA263
  • Published: 

Tools and resources

Tools and resources to help you put the guidance into practice.

Research recommendations

Guidance into practice